Northern Trust’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$38.1K Sell
23,110
-861
-4% -$1.42K ﹤0.01% 4276
2025
Q1
$37.9K Hold
23,971
﹤0.01% 4270
2024
Q4
$80.3K Sell
23,971
-13,319
-36% -$44.6K ﹤0.01% 4198
2024
Q3
$70.1K Sell
37,290
-365
-1% -$686 ﹤0.01% 4137
2024
Q2
$74.2K Buy
37,655
+704
+2% +$1.39K ﹤0.01% 4118
2024
Q1
$113K Hold
36,951
﹤0.01% 4046
2023
Q4
$86.1K Buy
+36,951
New +$86.1K ﹤0.01% 4143
2023
Q1
Sell
-4,971
Closed -$13.4K 4630
2022
Q4
$13.4K Hold
4,971
﹤0.01% 4543
2022
Q3
$20K Hold
4,971
﹤0.01% 4545
2022
Q2
$35K Hold
4,971
﹤0.01% 4512
2022
Q1
$58K Hold
4,971
﹤0.01% 4503
2021
Q4
$91K Sell
4,971
-3,560
-42% -$65.2K ﹤0.01% 4452
2021
Q3
$213K Buy
8,531
+3,057
+56% +$76.3K ﹤0.01% 4150
2021
Q2
$346K Sell
5,474
-16,374
-75% -$1.03M ﹤0.01% 3874
2021
Q1
$2.69M Buy
21,848
+412
+2% +$50.8K ﹤0.01% 3093
2020
Q4
$2.44M Sell
21,436
-441
-2% -$50.2K ﹤0.01% 3095
2020
Q3
$2.61M Buy
21,877
+3,787
+21% +$452K ﹤0.01% 2925
2020
Q2
$2.25M Buy
18,090
+11,725
+184% +$1.46M ﹤0.01% 2977
2020
Q1
$1.23M Buy
6,365
+4,273
+204% +$824K ﹤0.01% 3123
2019
Q4
$699K Sell
2,092
-109
-5% -$36.4K ﹤0.01% 3493
2019
Q3
$710K Buy
2,201
+698
+46% +$225K ﹤0.01% 3476
2019
Q2
$648K Buy
1,503
+115
+8% +$49.6K ﹤0.01% 3484
2019
Q1
$785K Buy
1,388
+22
+2% +$12.4K ﹤0.01% 3433
2018
Q4
$406K Sell
1,366
-2
-0.1% -$594 ﹤0.01% 3608
2018
Q3
$970K Buy
1,368
+431
+46% +$306K ﹤0.01% 3475
2018
Q2
$548K Sell
937
-17
-2% -$9.94K ﹤0.01% 3580
2018
Q1
$2.58M Buy
+954
New +$2.58M ﹤0.01% 2974